CADBRUFEN

This brand name is authorized in Nigeria.

Active ingredients

The drug CADBRUFEN contains a combination of these active pharmaceutical ingredients (APIs):

1	Ibuprofen UNII WK2XYI10QM - IBUPROFEN
	Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.
	Read more about Ibuprofen
2	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-0965	Tablet	CADBRUFEN TABLET TAB 200 mg; 325 mg 10 X 10	60 RNW-PP-336082 CADBRUFEN TABLET IBUPROFEN/PARACETAMOL IBUPROFEN 200MG AND PARACETAMOL 325MG B4-0965 Drugs Nigerian Products 10x10 OTC 6/20/2023 CARDINAL DRUGS LTD, , AJOKE OSHO STREET OWOYEMI ESTATE NEW OKO OBA AGEGE AGEGE LAGOS LAGOS 9036726918 olayodeolusina09@gmail.com CARDINAL DRUGS LIMITED, 14,AJOKE OSHO STREET, OFF OLANIYI STREET, OWOYEMI ESTATE, NEW OKO OBA,AGEGE,LAGOS STATE, Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE51	Ibuprofen, combinations	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-0965